Topical fluorouracil is FDA‑approved mainly for actinic (solar) keratoses on sun‑damaged skin and for superficial basal cell carcinoma in selected cases when surgery or other methods are less suitable.

Clinicians also use it off‑label for certain thin or superficial skin cancers, warts, and other precancerous lesions, typically supported by moderate clinical evidence and specialist guidelines rather than large randomized trials for every use.

For actinic keratoses, visible inflammation usually begins within days, lesions often start to clear within 2–4 weeks of treatment, and cosmetic outcomes are generally good once healing is complete.

For superficial basal cell carcinoma, treatment courses are longer (often several weeks), and many appropriately selected lesions are cleared, though surgery usually has higher cure rates and is still preferred for many skin cancers.

Compared with other field therapies (such as imiquimod or photodynamic therapy), fluorouracil is generally effective and inexpensive but can cause marked redness and irritation during use, and the choice among options often depends on lesion type, location, patient preference, and clinician experience.

For actinic keratoses, common regimens include applying 0.5% cream once daily or 2% solution or 5% cream/solution once or twice daily to the affected skin for about 2–4 weeks, or as directed by the prescriber; for superficial basal cell carcinoma, 5% preparations are often applied twice daily for several weeks (for example, up to 6 weeks) to the biopsy‑confirmed lesion and a small margin of surrounding skin.

Apply a thin film only to the prescribed areas on clean, dry skin, avoiding eyes, nostrils, mouth, and skin folds, and wash hands thoroughly after application unless hands are being treated.

Follow any special instructions about treatment duration, when to stop (often when the skin has reached a certain level of redness and crusting), and whether dressings, moisturizers, or sunscreens can be used during or after therapy.

If a dose is missed, apply it when remembered on the same day unless it is almost time for the next application, in which case skip the missed dose and resume the regular schedule without doubling doses.

In suspected overdose or accidental ingestion, or if very large skin areas have been treated contrary to instructions and the person feels unwell, seek emergency medical care or contact a poison control center immediately.

Common side effects of topical fluorouracil include redness, burning, stinging, itching, dryness, crusting, and scaling at the application site; these usually begin within a few days, peak during treatment, can be moderate to severe locally, and gradually improve after the drug is stopped.

Less common but more serious local reactions include ulceration, intense pain, severe swelling, or infection of treated areas, which require prompt medical attention, and rare systemic effects (such as severe fatigue, diarrhea, or mouth sores) may occur if large areas are treated or the drug is misused.

Use during pregnancy is generally avoided because fluorouracil is a chemotherapy agent with potential risk to an unborn baby; breastfeeding is usually not recommended on or near the breast area, and many clinicians prefer to avoid use in nursing mothers unless the benefit clearly outweighs the risk.

Safety and effectiveness in children have not been well established, so pediatric use is typically limited to specialist supervision; people with very sensitive skin, poor wound healing, or certain enzyme deficiencies (such as dihydropyrimidine dehydrogenase deficiency) may be at higher risk for adverse reactions.

Compared with many systemic chemotherapy drugs, topical fluorouracil has far fewer whole‑body side effects, but it can still cause strong local reactions and must be used exactly as directed, avoiding application to large areas unless prescribed.

Patients are generally advised to contact their healthcare provider if side effects are severe or unexpected, and they can report adverse effects to the FDA’s MedWatch program or equivalent national reporting systems for ongoing safety monitoring.

Because absorption from the skin is usually low, major drug–drug interactions are uncommon with topical fluorouracil, but caution is advised if the patient is taking systemic fluorouracil, capecitabine, or other chemotherapy that acts on the same pathway.

Use with other topical products that irritate or thin the skin (such as strong retinoids, abrasive cleansers, or alcohol‑containing preparations) can increase local irritation and should be done only under medical guidance.

Excessive sun exposure can worsen irritation and inflammation at treated sites; patients are generally advised to avoid sun, use protective clothing, and apply broad‑spectrum sunscreen to untreated skin as recommended by their clinician.

People with known dihydropyrimidine dehydrogenase (DPD) deficiency or a history of unusual toxicity to fluoropyrimidine chemotherapy should use topical fluorouracil only with extreme caution and close medical supervision, if at all.

Routine blood tests or heart monitoring are usually not required for typical limited‑area topical treatment, but a clinician may recommend additional monitoring when large body areas are treated, treatment is prolonged, or the patient has significant comorbidities.

Q: How long does it take for my skin to heal after using topical fluorouracil?
A: Redness, crusting, and irritation usually peak during the last week or two of treatment and begin to improve after the medication is stopped, with most people seeing much calmer, healing skin within 2–4 weeks, although full cosmetic recovery can take longer.

Q: Is it normal for my skin to look worse before it looks better?
A: Yes, treated areas typically become red, inflamed, and scabby as abnormal cells are destroyed, and this “worse before better” phase is expected and often indicates that the medicine is working, though severe pain or ulceration should be reported to your prescriber.

Q: Can I go in the sun while using fluorouracil cream?
A: Sun exposure usually makes irritation worse and can damage healing skin, so it is best to avoid direct sun on treated areas, use protective clothing, and follow your clinician’s advice about sunscreen use.

Q: Can I use moisturizers or makeup with fluorouracil?
A: Many clinicians allow bland, fragrance‑free moisturizers on or around treated skin (often after the medicine has dried), but makeup is usually discouraged on actively treated, inflamed areas; always follow your prescriber’s specific instructions.

Q: What should I do if I accidentally get fluorouracil in my eyes or mouth?
A: Rinse the area immediately with plenty of water, remove any remaining cream, and contact a healthcare professional or poison control center right away if irritation persists or if the medicine was swallowed.

Store topical fluorouracil at room temperature (generally around 68–77°F or 20–25°C), tightly closed, away from heat, excessive moisture, and direct light, and do not freeze unless the product label specifically allows it.

Keep the medication out of reach of children and pets, avoid contact with eyes, mouth, and healthy skin, and caregivers applying it should wash hands well afterward or use disposable gloves.

For disposal, use a community drug take‑back program if available, or follow pharmacist or local waste authority instructions; do not flush the medicine down the toilet or pour it into drains unless specifically told to do so.